Evidence map›Paper›PMID 37818393›Full record

ArticleJAC-antimicrobial resistance2023

Exploring drivers and challenges influencing antibiotic prescribing in outpatient settings and possible mitigation strategies in the United Arab Emirates: a qualitative study.

Ahmed A Sadeq, Farah Ahmed Issa, Mina Bakhit, Maitha Abdul-Aziz Al-Tamimi, Zahir Osman Eltahir Babiker, Raghad S Ismail Alshabebi, Jehad Abdallah, Emmanuel Fru Nsutebo, Marleine B Moukarzel, Rawan Abukhater and 4 more

Abstract read
In one paragraph

Article in JAC-antimicrobial resistance, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Ahmed A SadeqDepartment of Pharmacy, Shaikh Shakhbout Medical City in Partnership with Mayo Clinic, Abu Dhabi, PO BOX 11001, United Arab Emirates.
Farah Ahmed IssaDepartment of Medicine, Shaikh Shakhbout Medical City in Partnership with Mayo Clinic, Abu Dhabi, PO BOX 11001, United Arab Emirates.
Mina BakhitInstitute for Evidence-Based Healthcare, Bond University, Gold Coast, QLD 4226, Australia.ORCID https://orcid.org/0000-0002-6162-3362
Maitha Abdul-Aziz Al-TamimiDepartment of Pharmacy, Shaikh Shakhbout Medical City in Partnership with Mayo Clinic, Abu Dhabi, PO BOX 11001, United Arab Emirates.
Zahir Osman Eltahir BabikerDivision of Infectious Diseases, Shaikh Shakhbout Medical City in Partnership with Mayo Clinic, Abu Dhabi, PO Box 11001, United Arab Emirates.ORCID https://orcid.org/0000-0002-6129-4597
Raghad S Ismail AlshabebiDepartment of Intensive Care, Shaikh Shakhbout Medical City in Partnership with Mayo Clinic, Abu Dhabi, PO BOX 11001, United Arab Emirates.
Jehad AbdallahInfectious Disease Department, Al Rahba Hospital, Abu Dhabi Health Services (SEHA), Abu Dhabi, United Arab Emirates.
Emmanuel Fru NsuteboDivision of Infectious Diseases, Shaikh Shakhbout Medical City in Partnership with Mayo Clinic, Abu Dhabi, PO Box 11001, United Arab Emirates.
Marleine B MoukarzelDepartment of Pharmacy, Shaikh Shakhbout Medical City in Partnership with Mayo Clinic, Abu Dhabi, PO BOX 11001, United Arab Emirates.
Rawan AbukhaterDepartment of Medicine, Shaikh Shakhbout Medical City in Partnership with Mayo Clinic, Abu Dhabi, PO BOX 11001, United Arab Emirates.
Barbara R ConwayDepartment of Pharmacy, School of Applied Sciences, University of Huddersfield, Huddersfield HD1 3DH, UK.
Stuart E BondDepartment of Pharmacy, School of Applied Sciences, University of Huddersfield, Huddersfield HD1 3DH, UK.ORCID https://orcid.org/0000-0001-9640-2474
Sidra KhanDepartment of Pharmacy, School of Applied Sciences, University of Huddersfield, Huddersfield HD1 3DH, UK.
Mamoon A AldeyabDepartment of Pharmacy, School of Applied Sciences, University of Huddersfield, Huddersfield HD1 3DH, UK.ORCID https://orcid.org/0000-0001-8148-7612

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objectives: Healthcare institutions implement antimicrobial stewardship (AMS) programmes to optimize the use of antibiotics. The focus is often on inpatient rather than outpatient settings. We aimed to explore perceptions of AMS stakeholders on effective interventions for appropriate antibiotic use in outpatient settings, and the role of clinical pharmacists in the AMS multidisciplinary team. Methods: A qualitative semi-structured interview study using thematic analysis by two researchers independently. Participants that practice AMS programmes were recruited from healthcare facilities in the United Arab Emirates (UAE). Interviews were conducted face to face or online and transcribed verbatim. Results: Four themes emerged: (i) Perceived factors leading to unnecessary or inappropriate antibiotic prescribing and their impact on patients and the community; (ii) current outpatient AMS activities and perceived barriers and facilitators for their sustainability; (iii) suggested outpatient AMS strategies to be implemented in outpatient settings; and (iv) perceived future AMS implementation barriers and suggested mitigation strategies. Conclusions: Several AMS interventions, together with the presence of a clinical pharmacist, may be effective in improving antibiotic use in UAE outpatient settings. Future research should investigate the most appropriate AMS strategy considering barriers and possible mitigation strategies to ensure sustainability.

Identifiers

PMID37818393
PMCPMC10561535

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.